FDA guidance
Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for…
FDA guidance · Draft · issued Dec 19, 2019
Key facts
| Title | Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for Industry |
|---|---|
| Status | Draft |
| Issue date | Dec 19, 2019 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, Office of the Commissioner… |
| Communication type | Guidance Document |
| Regulated product | Biologics, Drugs, Medical Devices |
| Docket number | FDA-2019-D-5585 |
| Comments close | Feb 18, 2020 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents